Publications

 

Below are the Vaccine Trials Groups publications for 2006.

Should you wish to search for publications authored by our researchers, please use PubMed Central (PMC) - the US National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature.

>> Click here to connect to PubMed Central.

Skinner, SR., Kang M. HPV prevalence in Canberra high school students: significance for vaccination strategies and adolescent health. Sexual Health. Vol. 3(4)(pp 299-300), 2006.

 

Skinner SR, Kang M., Rosenthal SL. Vaccinating young adults against HPV: the importance of understanding health decision-making and behaviour. Sexual Health (in press, accepted Mar 2007)

 

Jacquet JM, Bégué P, Grimprel E, Richmond P et al. Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review Vaccine 2006; 24:2440-8.

 

Goldblatt D, Southern J, Ashton L, Richmond P, et al. Immunogenicity and boosting following a reduced number of doses of a Pneumococcal Conjugate Vaccine in infants and toddlers. Pediatric Infectious Disease J 2006 25(4):312-9.

 

Taylor R, Richmond P, Upham J. Toll-like receptor 2 ligands inhibit Th2 responses to mite allergen J Allergy Clinical Immunology 2006;117:1148-54

 

Marshall H, H. Nolan T, Roberton D, Richmond P et al A comparison of booster immunisation with a combination DTPa-IPV vaccine or DTPa plus IPV in separate injections when co-administered with MMR, at age 4 – 6 years. Vaccine 2006; 24(35-36):6120-8.

 

Galati JC, Harsley S, Richmond P., Carlin JB. The burden of rotavirus-related illness among young children on the Australian health care system. ANZ J Public Health 2006; 30:416-21

 

Moore H, Burgner D, Carville KS, Jacoby P, Richmond P, Lehmann D. Diverging trends for lower respiratory infections in non-Aboriginal and Aboriginal children J Paediatrics and Child Health (in press, accepted October 2006)

 

Carville KS, Lehmann D, Hall G, Moore H, Richmond P, deKlerk N, Burgner D. Infection is the major component of the disease burden in Aboriginal and non-Aboriginal Australian children: a population-based study. Pediatric Infectious Disease J (In press, accepted Oct 2006)

 

Yerkovich ST, Rowe J, Richmond P, Suriyaarachchi D, Heaton T, Hollams E, Ladyman C, Serralha M, Sadowska A, Loh R, Wesselingh SL, Sly PD Holt PG. Assessment of the potency and potential immunomodulatory effects of the Measles Mumps Rubella-Varicella vaccine in infants. Vaccine 2007; 25:1764-70.

 

Noakes P, Taylor A, Hale J, Breckler L, Richmond P, Devadason SG, Prescott SL. The effects of maternal smoking on early mucosal immunity and sensitization at 12 months of age. Pediatr Allergy Immunol. 2007;18:118-27

 

Nolan T, Lambert S, Roberton D, Marshall H, Richmond P, Streeton C. A DTPa-HBV-IPV vaccine for primary vaccination of infants. J Paediatrics and Child Health (in press, accepted December 2006)

 

Block SL, Nolan T, Sattler C, Protocol 016 Study Group et al. Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papilloma Virus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics. 2006; 118:2135-45.